Our AI instantly delivers powerful, actionable diabetes insights from one of the world’s richest diabetes datasets.
Concerns about family or friends getting COVID-19 and about getting COVID-19 oneself increased, as case numbers rose nationally over the summer.
Our fifth COVID-19 impact survey shows Black & Latino adults with diabetes faced more COVID-19 cases, insulin rationing, and financial strain.
Our research with the ADA reveals severe economic impacts of COVID-19 on Americans with diabetes, including high unemployment and care rationing.
Our fourth COVID-19 survey of U.S. diabetes patients highlights persistent concerns, economic stress, and changing behaviors despite easing lockdowns.
dQ&A reveals how Walmart’s CareZone deal, low mail-order NPS scores, and a pandemic push toward home delivery are reshaping pharmacy apps for diabetes.
Our hearts are heavy at the pain felt by the Black community. We are committed to working towards a more equitable future, and we invite you to join us.
Our third COVID-19 survey of U.S. diabetes patients found high infection concern, income loss, care changes, and challenges accessing healthy food and supplies.
dQ&A analyzes telemedicine diabetes care during COVID-19—trends, patient experiences, and what's next for virtual visits amid evolving healthcare needs.
